Brief: Xvivo Perfusion Q2 EBITDA ex-items down at SEK 6.2 mln
July 14 (Reuters) - XVIVO PERFUSION AB XVIVO.ST :
* Q2 EBITDA EX-ITEMS SEK 6.2 MILLION VERSUS SEK 6.9
MILLION YEAR AGO
* Q2 NET SALES SEK 37.0 MILLION VERSUS SEK 34.5 MILLION
YEAR AGO
Source text for Eikon: ID:nWkr6V7SbF
Further company coverage: XVIVO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength